State Street
FBLG icon

State Street’s FibroBiologics FBLG Stock Holding History

State Street’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,565
Closed -$25K – 4349
2025
Q4 		$25K Hold
5,565
– – ﹤0.01% 4226
2025
Q3 		$60.8K Sell
5,565
-210
-4% -$2.52K ﹤0.01% 4132
2025
Q2 		$71.9K Sell
5,775
-22,548
-80% -$407K ﹤0.01% 4033
2025
Q1 		$510K Sell
28,323
-403
-1% -$11.5K ﹤0.01% 3584
2024
Q4 		$1.15M Buy
28,726
+4,934
+21% +$265K ﹤0.01% 3458
2024
Q3 		$1.47M Buy
23,792
+4,990
+27% +$332K ﹤0.01% 3411
2024
Q2 		$1.88M Buy
+18,802
New +$3.59M ﹤0.01% 3339

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM